GENEX BONE GRAFT SUBSTITUTE— 510(k) K040600

Name: FDA 510(k) clearance K040600
Creator: U.S. Food and Drug Administration
Published: 2004-05-07

Substantially Equivalent

Biocomposites, Ltd.

FDA 510(k) clearance K040600 for GENEX BONE GRAFT SUBSTITUTE, Substantially Equivalent on 2004-05-07. Applicant: Biocomposites, Ltd.. Device class: 2.

Clearance details

Applicant: Biocomposites, Ltd.
Product code: Code MQV
Device class: Class 2
Regulation: 21 CFR 888.3045
Advisory panel: Orthopedic
Date received: 2004-03-08
Decision date: 2004-05-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Stoke On Trent, GB

Download summary PDF View on FDA.gov ↗

Recent devices under product code MQV

view all

K262230 — Mg OSTEOREVIVE; Mg OSTEOCRETE2026-09-11
K260364 — Device 300419 Strip2026-06-02
K252797 — JAZBI Resorbable Bone Void Filler2026-05-26
K261008 — Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip +7 more2026-04-24
K253524 — Adaptos®Fuse Bone Graft2026-02-17

More clearances from Biocomposites, Ltd.

view all

K251680 — Biosteon® Screw2026-02-17
K242865 — Synicem Hip Spacer; Synicem Knee Spacer; Synicem Shoulder Spacer2025-06-12
K250521 — NanoBone® SBX Putty; NanoBone® QD2025-04-07
K212721 — Genex Bone Graft Substitute2022-02-04
K141830 — STIMULAN KIT, STIMULAN RAPID CURE2015-01-23

Adverse events under product code MQV

product code MQV

Death: 6
Injury: 435
Total: 441

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.